Performance of NOVO-B (Novo Nordisk A/S) - Total Returns
| TimeFrame |
NOVO-B |
XBI |
| 1 Day |
-1.25%
|
0.94% |
| 1 Week |
-1.58% |
7.70% |
| 1 Month |
-3.22% |
13.82% |
| 3 Months |
2.23% |
-0.44% |
| 6 Months |
21.13% |
-9.73% |
| 12 Months |
54.78% |
-1.30% |
| YTD |
47.68% |
-4.17% |
| Rel. Perf. 1m |
-1.40
|
|
| Rel. Perf. 3m |
2.99
|
|
| Rel. Perf. 6m |
3.26
|
|
| Rel. Perf. 12m |
5.16
|
|
Comparison with the Market (Total Return): Values above 0%: NOVO-B is performing better - Values below 0%: NOVO-B is underperforming
|
Symbol |
1w |
1m |
6m |
12m |
| US S&P 500 |
SPY |
-1.61% |
-7.60% |
14.11% |
37.49% |
| US NADSAQ 100 |
QQQ |
-0.36% |
-7.51% |
12.31% |
17.16% |
| US Dow Jones Industrial 30 |
DIA |
-3.43% |
-9.35% |
12.63% |
45.27% |
| German DAX 40 |
DBXD |
-4.65% |
-13.30% |
16.97% |
39.38% |
| UK FTSE 100 |
ISFU |
-2.27% |
-6.50% |
19.34% |
48.04% |
| Shanghai Shenzhen CSI 300 |
CSI 300 |
1.37% |
1.63% |
31.50% |
69.18% |
| Hongkong Hang Seng |
HSI |
1.41% |
4.82% |
32.52% |
66.85% |
| Japan Nikkei 225 |
EXX7 |
-3.28% |
-6.70% |
25.44% |
45.57% |
| India NIFTY 50 |
INDA |
-5.33% |
-10.35% |
8.90% |
44.84% |
| Brasil Bovespa |
EWZ |
-1.14% |
-8.28% |
11.17% |
34.24% |
| Bitcoin |
BTC |
-17.13% |
-28.08% |
-39.47% |
-101.20% |
|
Symbol |
1w |
1m |
6m |
12m |
| Communication Services |
XLC |
0.51% |
-5.19% |
12.62% |
15.10% |
| Consumer Discretionary |
XLY |
-2.75% |
-9.81% |
13.26% |
31.06% |
| Consumer Staples |
XLP |
-2.07% |
-5.31% |
23.44% |
59.54% |
| Energy |
XLE |
0.93% |
1.20% |
17.06% |
55.16% |
| Financial |
XLF |
-2.34% |
-9.43% |
11.89% |
49.69% |
| Health Care |
XLV |
-3.38% |
-6.14% |
18.51% |
57.12% |
| Industrial |
XLI |
-4.06% |
-10.32% |
12.67% |
43.77% |
| Materials |
XLB |
-0.94% |
-6.64% |
17.50% |
53.06% |
| Real Estate |
XLRE |
-4.29% |
-12.75% |
16.39% |
51.35% |
| Technology |
XLK |
-0.48% |
-8.99% |
10.44% |
13.09% |
| Utilities |
XLU |
-3.47% |
-6.41% |
22.15% |
62.30% |
| Aerospace & Defense |
XAR |
-4.48% |
-10.83% |
9.56% |
35.12% |
| Biotech |
XBI |
-9.28% |
-17.04% |
30.86% |
56.08% |
| Homebuilder |
XHB |
-6.33% |
-16.62% |
3.53% |
9.61% |
| Retail |
XRT |
-4.38% |
-11.02% |
10.48% |
50.53% |
|
Symbol |
1w |
1m |
6m |
12m |
| Oil |
USO |
9.12% |
10.33% |
19.61% |
55.50% |
| Natural Gas |
UNG |
6.59% |
22.59% |
39.65% |
123.91% |
| Gold |
GLD |
-0.68% |
-5.67% |
18.11% |
40.83% |
| Silver |
SLV |
2.57% |
-7.25% |
19.84% |
47.49% |
| Copper |
CPER |
1.04% |
-2.96% |
21.52% |
54.69% |
|
Symbol |
1w |
1m |
6m |
12m |
| iShares 20+ Years Bond |
TLT |
-5.41% |
-14.04% |
25.79% |
62.10% |
| iShares High Yield Corp. Bond |
HYG |
-2.08% |
-6.08% |
16.38% |
46.76% |
Why you need a Total Return Perfomance Comparison?
Comparing the Total Return of Novo Nordisk A/S with its related sector or the XBI index is a fundamental analysis that provides investors with a comprehensive perspective on the company's performance.
Total Return encompasses not just stock price changes but also factors in dividends and other income sources, offering a more holistic view of investment outcomes.
This comparison allows investors to assess how Novo Nordisk A/S returns stack up against the performance of its broader sector, the XBI index.
Ratings above 1 on the
Relative Performance Scale signify that the investment is performing well, while a rating exceeding 2 indicates exceptional performance.
Consequently, this analysis assists investors in making well-informed decisions about their investments by providing insights into whether Novo Nordisk A/S is outperforming or underperforming its sector in terms of total returns.
